<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>619</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15494538</PubmedId>
            <Abstract>T cells play an important role in the control of human CMV (HCMV) infection. Peripheral blood CD4+ T cell proliferative responses to the HCMV lower tegument protein pp65 have been detected in most healthy HCMV carriers. To analyze the clonal composition of the CD4+ T cell response against HCMV pp65, we characterized three MHC class II-restricted peptide epitopes within pp65 in virus carriers. In limiting dilution analysis, we observed high frequencies of pp65 peptide-specific CD4+ T cells, many of which expressed peptide-specific cytotoxicity in addition to IFN-gamma secretion. We analyzed the clonal composition of CD4+ T cells specific for defined HCMV peptides by generating multiple independent peptide-specific CD4+ clones and sequencing the TCR beta-chain. In a given carrier, most of the CD4+ clones specific for a defined pp65 peptide had identical TCR nucleotide sequences. We used clonotype oligonucleotide probing to quantify the size of individual peptide-specific CD4+ clones in whole PBMC and in purified subpopulations of CD45RAhighCD45ROlow and CD45RAlowCD45ROhigh cells. Individual CD4+ T cell clones could be large (0.3-1.5% of all CD4+ T cells in PBMC) and were stable over time. Cells of a single clone were distributed in both the CD45RAhigh and CD45ROhigh subpopulations. In one carrier, the virus-specific clone was especially abundant in the small CD28-CD45RAhigh CD4+ T cell subpopulation. Our study demonstrates marked clonal expansion and phenotypic heterogeneity within daughter cells of a single virus-specific CD4+ T cell clone, which resembles that seen in the CD8+ T cell response against HCMV pp65.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>5843-51</ArticlePages>
            <ArticleTitle>Long-term stable expanded human CD4+ T cell clones specific for human cytomegalovirus are distributed in both CD45RAhigh and CD45ROhigh populations.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Weekes</LastName>
                    <ForeName>Michael P</ForeName>
                </Author>
                <Author>
                    <LastName>Wills</LastName>
                    <ForeName>Mark R</ForeName>
                </Author>
                <Author>
                    <LastName>Sissons</LastName>
                    <ForeName>J G Patrick</ForeName>
                </Author>
                <Author>
                    <LastName>Carmichael</LastName>
                    <ForeName>Andrew J</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Medicine, University of Cambridge Clinical School, Cambridge, United Kingdom.</Affiliations>
            <ArticleChemicalList>CD28 Antigens;Epitopes, T-Lymphocyte;Histocompatibility Antigens Class II;Peptide Fragments;Phosphoproteins;Viral Matrix Proteins;cytomegalovirus matrix protein 65kDa;Leukocyte Common Antigens</ArticleChemicalList>
            <ArticleMeshHeadingsList>Alleles; Amino Acid Sequence; CD28 Antigens(biosynthesis); CD4-Positive T-Lymphocytes(cytology; immunology; virology); Cell Division(immunology); Clone Cells; Cytomegalovirus(immunology); Epitopes, T-Lymphocyte(immunology; metabolism); Histocompatibility Antigens Class II(genetics); Humans; Immunologic Memory; Leukocyte Common Antigens(biosynthesis); Lymphocyte Count(methods); Molecular Sequence Data; Peptide Fragments(immunology; metabolism); Phosphoproteins(immunology; metabolism); T-Lymphocyte Subsets(cytology; immunology; virology); Time Factors; Viral Matrix Proteins(immunology; metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>173</Volume>
                <Issue>9</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>41-60</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LLQTGIHVRVSQPSLILVSQ</LinearSequence>
                        <StartingPosition>41</StartingPosition>
                        <EndingPosition>60</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>YP_002608275.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>37723</EpitopeId>
                <ReferenceStartingPosition>41</ReferenceStartingPosition>
                <ReferenceEndingPosition>60</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The authors indicate that a likely minimal epitope has been previously identified comprising residues 47 to 58.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table I</LocationOfData>
                        <TCellId>5837</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10359</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HHV-5</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenReferenceName>41-60</ImmunogenReferenceName>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LLQTGIHVRVSQPSLILVSQ</LinearSequence>
                                            <StartingPosition>41</StartingPosition>
                                            <EndingPosition>60</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>YP_002608275.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10359</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The blood donor was HIV infected and HCMV (Herpesvirus 5)  seropositive. CD4+ cells were stimulated with overlapping 20-mer pools of peptides from the HCMV protein pp65. For positive pools, individual peptides were retested The MHC restriction was established using CD4+ clones derived from responding cells.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>89</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>41-60</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LLQTGIHVRVSQPSLILVSQ</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>60</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>YP_002608275.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10359</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>In addition to the information captured here, the authors characterize the CD4+ clones in terms of presence of CD45 receptors and rearrangement of the TCR chains and clonotype frequencies.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>259-273</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NPQPFMRPHERNGFT</LinearSequence>
                        <StartingPosition>249</StartingPosition>
                        <EndingPosition>263</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA45994.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>45461</EpitopeId>
                <ReferenceStartingPosition>259</ReferenceStartingPosition>
                <ReferenceEndingPosition>273</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table I</LocationOfData>
                        <TCellId>5839</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10359</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HHV-5</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenReferenceName>367-380</ImmunogenReferenceName>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NPQPFMRPHERNGFT</LinearSequence>
                                            <StartingPosition>249</StartingPosition>
                                            <EndingPosition>263</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA45994.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10359</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The blood donor was HIV infected and HCMV (Herpesvirus 5)  seropositive. CD4+ cells were stimulated with overlapping 20-mer pools of peptides from the HCMV protein pp65. For positive pools, individual peptides were tested and truncated to identify the minimal epitope. The MHC restriction was established using CD4+ clones derived from responding cells.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>333</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>259-273</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NPQPFMRPHERNGFT</LinearSequence>
                                        <StartingPosition>249</StartingPosition>
                                        <EndingPosition>263</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA45994.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10359</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>In addition to the information captured here, the authors characterize the CD4+ clones in terms of presence of CD45 receptors and rearrangement of the TCR chains and clonotype frequencies.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>367-380</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PTFTSQYRIQGKLE</LinearSequence>
                        <StartingPosition>367</StartingPosition>
                        <EndingPosition>380</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>YP_002608275.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>49628</EpitopeId>
                <ReferenceStartingPosition>367</ReferenceStartingPosition>
                <ReferenceEndingPosition>380</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table I</LocationOfData>
                        <TCellId>5840</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10359</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HHV-5</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenReferenceName>259-273</ImmunogenReferenceName>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>PTFTSQYRIQGKLE</LinearSequence>
                                            <StartingPosition>367</StartingPosition>
                                            <EndingPosition>380</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>YP_002608275.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10359</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The blood donor was HIV negative and HCMV (Herpesvirus 5)  seropositive. CD4+ cells were stimulated with overlapping 20-mer pools of peptides from the HCMV protein pp65. For positive pools, individual peptides were tested and truncated to identify the minimal epitope. The MHC restriction was established using CD4+ clones derived from responding cells.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>330</MhcAlleleId>
                            <MhcEvidenceCode>Statistical association</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>367-380</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PTFTSQYRIQGKLE</LinearSequence>
                                        <StartingPosition>367</StartingPosition>
                                        <EndingPosition>380</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>YP_002608275.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10359</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>In addition to the information captured here, the authors characterize the CD4+ clones in terms of presence of CD45 receptors and rearrangement of the TCR chains and clonotype frequencies.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

